Recall Z-1017-2024

Becton Dickinson & Co. · initiated January 8, 2024

Class II Open, Classified

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

BD BBL Sensi Disc Cefaclor - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653

Codes / lots: Catalog No. 231653¿ UDI-DI 30382902316535 Lots 1085898 1273095 1273096 2004485 2147706 2333108

Reason for recall

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

FDA-determined cause: Process control

Action taken

On January 8, 2024, the firm notified customers through URGENT Medical Device Product Correction letters. Users were instructed to cease use of catalog number 291270, and to refrain from conducting AST for H. influenzae with impacted Sensi-Discs. Customers should destroy any units of catalog number 291270 in their inventory. Customers should share and post the recall notification within their facility network and forward to any customers to whom they may have distributed the product. Future lots of affected Sensi-Disc products (excluding catalog number 291270) will be labeled with a sticker notifying customers "This product should not be used for the semi-quantitative in vitro susceptibility testing of Haemophilus influenzae." Identify impacted lot numbers: https://legacy.bd.com/alerts-notices/IDS-23-4851.asp For customer questions: Phone: 1-844-823-5433 Say "Recall when prompted Mon-Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com

Details

Recall number
Z-1017-2024
Initiated
January 8, 2024
Posted by FDA
February 8, 2024
Product code
JTN – Susceptibility Test Discs, Antimicrobial
Quantity
2,363,168 total units
Distribution
Domestic distribution nationwide. International distribution worldwide.
Recalling firm
Becton Dickinson & Co., Sparks, MD

Official FDA recall record

Other products in the same recall event

RecallProductInitiated
Z-1011-2024 Class IISensi Disc Amoxicillin with Clavulanic Acid 20/10 g, Catalog No. 231628 and 231629.…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1012-2024 Class IIBD BBL Sensi Disc Ampicillin - 10 g, Catalog No. 230705 and 231264; 2 g, Catalog No.…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1013-2024 Class IIBD BBL Sensi Disc Ampicillin with Sulbactam 10/10 g, Catalog Number 231660. Used for…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1014-2024 Class IIBD BBL Sensi Disc Augmentin - 3g, Catalog Number 291270used for semi-quantitative in…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1015-2024 Class IIBD BBL Sensi Disc Azithromycin -15 g, Catalog Number 231682used for semi-quantitative in…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1016-2024 Class IIBD BBL Sensi Disc Aztreonam - 30 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1018-2024 Class IIBD BBL Sensi Disc Cefepime - 30 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1019-2024 Class IIBD BBL Sensi Disc Cefixime - 5 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1020-2024 Class IIBD BBL Sensi Disc Cefotaxime - 30 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1021-2024 Class IIBD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1022-2024 Class IIBD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1023-2024 Class IIBD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1024-2024 Class IIBD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1025-2024 Class IIBD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1026-2024 Class IIBD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1027-2024 Class IIBD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1028-2024 Class IIBD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1029-2024 Class IIBD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1030-2024 Class IIBD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1031-2024 Class IIBD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1032-2024 Class IIBD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1033-2024 Class IIBD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1034-2024 Class IIBD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1035-2024 Class IIBD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1036-2024 Class IIBD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1037-2024 Class IIBD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1038-2024 Class IIBD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1039-2024 Class IIBD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified
Z-1040-2024 Class IIBD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility…There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing… 01/08/2024Open, Classified